Irrespective of the COVID-19 pandemic, demand for biological and chemical indicators has been surging tremendously as sterilization has always been at forefront of duties of healthcare facilities.

Biological & Chemical Indicators Market Size Study

• Thermal sterilization will remain the preferred sterilization type through 2030
• Biological indicators (BI) continue to stay high in demand, enzyme indicators to gain traction
• Players to stay glued to self-contained BIs, as they lead to shorter required incubation times
• Biopharma industry to remain primary end-user of biological and chemical indicators over the following decade
• Stakeholders to reap substantial revenue from North America and Europe, given the presence of advanced healthcare infrastructure

Regional Outlook

• North America (US, and Canada)
• Latin America (Brazil, and Mexico)
• Europe (Germany, UK, Russia, France, and Italy)
• South Asia (India, Indonesia, Thailand, Australia, and New Zealand)
• East Asia (China, Japan, and South Korea)
• Oceania (Australia and New Zealand)
• the Middle East & Africa (MEA) (Turkey, GCC Countries, and South Africa)

To remain ahead of your competitors, Request a Sample Copy